PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
14-Jan-2026 $33.17 Bn Drug Addiction Treatment Markets, 2019-2024, 2024-2029F, 2034F - ResearchAndMarkets.com Businesswire
14-Jan-2026 Drug Analytical Method Validation, Verification and Transfer Virtual Seminar (Jan 14th - Jan 15th, 2026 and On-Demand) - ResearchAndMarkets.com Businesswire
14-Jan-2026 Wesleyan Impact Partners Receives $5 Million Grant from Lilly Endowment Businesswire
14-Jan-2026 Auditing and Qualifying Suppliers and Vendors: An Effective Risk-based Approach Training Course (Mar 3rd - Mar 5th, 2026) - ResearchAndMarkets.com Businesswire
14-Jan-2026 US, EU and Canada Dietary Supplements Regulatory Compliance Training Course: Strengthening FDA Readiness, GMP Standards, and Formulation Quality (Jan 15th - Jan 16th, 2026 on ON-DEMAND) - ResearchAndMarkets.com Businesswire
14-Jan-2026 Hazeltree 2025 Year-in-Review Finds Hedge Fund Crowding Diverged Sharply by Region Businesswire
14-Jan-2026 Hazeltree 2025 Year-in-Review Finds Hedge Fund Crowding Diverged Sharply by Region Businesswire
14-Jan-2026 Dr. Reddy’s Announces the First-to-Market Launch of Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC), the Generic Equivalent of Extra-Strength Pataday® Once Daily Relief, in the U.S. Businesswire
14-Jan-2026 OSI Systems Receives $12 Million Order for Optical Sensors Businesswire
14-Jan-2026 Saudi FDA Grants Accelerated Approval to ImmunityBio’s ANKTIVA® In Combination with Checkpoint Inhibitors for Metastatic Non-Small Cell Lung Cancer Businesswire
14-Jan-2026 Saudi FDA Grants Accelerated Approval to ImmunityBio’s ANKTIVA® for Non-Muscle Invasive Bladder Cancer with Carcinoma In-Situ Businesswire
14-Jan-2026 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
14-Jan-2026 Recovery Takes Hold as Infrastructure and Renewables Accelerate Canada’s Construction Growth Into 2026, says Linesight Businesswire
14-Jan-2026 Fresenius Kabi, TQ Therapeutics Announce Cell Therapy Technology Agreement Businesswire
14-Jan-2026 WEP Clinical Acquires Netherlands-Based CRO Siron Clinical, Expanding Global Phase I–IV Trial Delivery Capabilities Businesswire
14-Jan-2026 Immunis Announces Preliminary Results from First-Ever Phase 2 Study of a Secretome-Based Biologic Showing Weight Loss with Preserved Muscle and Improved Gait Speed in Obese Sarcopenic Seniors Businesswire
14-Jan-2026 BBWI BREAKING NEWS: Bath & Body Works, Inc. Failed Sales Strategy Triggers Securities Fraud Class Action after Stock Drops Over 24% -- Investors are Notified to Contact BFA Law by March 13 Businesswire
14-Jan-2026 Caldera Therapeutics Launches with $112.5 Million and Announces First Subjects Dosed in Phase 1 Trial of First-In-Class Bispecific Antibody CLD-423 for Inflammatory Bowel Disease Businesswire
14-Jan-2026 The Coca-Cola Company Announces Changes in Operational Leadership and Creation of New Enterprise Role to Accelerate Digital Transformation Businesswire
14-Jan-2026 Almirall Presents R&D Pipeline Advances Supported by Sustained Growth and Leadership in Medical Dermatology at J.P. Morgan Healthcare Conference Businesswire